维普中文期刊产品整合服务
67篇 您的检索式:作者名="Treleaven"
    题名 作者 年代 出处 被引量
1The thermal conductivity of ribbon-shaped carbon fibers显示文摘N.C. Gallego D.D. Edie B. Nysten J.P. Issi J.W. Treleaven G.V. Deshpande 2000Carbon2000,,7:2
2Sensorimotor function and dizziness in neck pain: implications for assessment and management显示文摘Kristjansson E Treleaven J 2009J Orthop Sports Phys Ther2009,39,5:1
3Utility of ultrasonographic venous assessment prior to forearm arteriovenous fistula creation 显示文摘Brimble KS Rabbat Ch G Treleaven DJ 2002Clin Nephrol2002,58,2:1
4Conflict Resolution and Traffic Complexity of Multitde Intersecting Flows of Aircraft显示文摘Treleaven K Mao Z H 2008IEEE Transactions on Intelligent Transportation Systems2008,9,4:1
5Conflict resolution and traffic complexity of multiple intersecting flows of aircraft显示文摘K Treleaven Z H Mao 2008Intelligent Transpor- tation Systems 1EEE Transactions on2008,9,4:1
6Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force显示文摘Treleaven J Gennery A Marsh J 2011Br J Haematol2011,152,1:1
7The role of posttransplantation maintenance chemotherapy in improving the outcome of autotransplantation in adult acute lymphoblastic leukemia 显示文摘Powles R Sirohi B Treleaven J 2002Blood2002,100,:1
8英国血液学标准委员会输血工作组辐照血液使用指南(1)显示文摘颁布本指南的目的是为辐照输血的合理使用提供一个明确的专业指导,即在什么情况下需要使用辐照血液成分,同时阐明在辐照血液成分使用过程中存在的利与弊。Treleaven J Gennery A,Marsh J 陈峰(节译) 朱发明(审校) 2012国际输血及血液学杂志2012,35,5:1
9Short residence time graphitization of mesophase pitch-based carbon fibers显示文摘M L GREENE R W SCHWARTZ J W TRELEAVEN 2002Carbon2002,40,:1
10Short residence time graphitization of mesophase pitch-based carbon fibers 显示文摘GREENE M L SCHWARTZ R W TRELEAVEN J W 2002Carbon2002,40,8:1
11Sensorimotor function and dizziness inneck pain:implications for assessment and management显示文摘Kristjansson E Treleaven J 2009J Orhop Sports Phys Ther2009,5,:1
12The relationship of cervical joint position error to balance and eye movement disturbances in persistent whiplash 显示文摘Treleaven J Jull G LowChoy N 2006Man Ther2006,11,2:1
13Manual examination:is pain provocation a major cue for spinal dysfunction?显示文摘Jull G Treleaven J Versace G 1994Australian Journal of Physiotherapy1994,40,3:1
14Comparison of sensorimotor disturbance between subjects with persistent whiplash-associated disorder and subjects with vestibular pathology associated with acoustic neuroma 显示文摘Treleaven J LowChoy N Darnell R 2008Arch Physl Med Rehabil2008,89,3:1
15Algorithmic trading review显示文摘Philip Treleaven Michal Galas Vidhi Lalc hand 2013Communications of the ACM2013,56,:1
16Efficacy and safety of non-vitamin K antagonist oral anticoagulants post-kidney transplantation显示文摘BACKGROUND Novel oral anticoagulants(NOACs)were developed as alternatives to vitamin K antagonists,primarily warfarin,as they do not require routine monitoring and have limited drug-drug and drug-food interactions.However,the efficacy and safety of these agents in kidney transplantation are not well studied.AIM To assess the profile and safety of NOACs for patients who had kidney transplantation,and to provide recommendations and guidelines on therapeutic strategies in these patients.METHODS This was a retrospective study carried out among adult patients who were actively on the following NOACs(apixaban,rivaroxaban or dabigatran)in our renal transplantation program from December 2015 to December 2016.The patients were identified primarily through electronic medical record system(patient data linkage).Data on the clinical and laboratory profile of the patients were retrieved and analyzed with SPSS 22.0.RESULTS Complete data on 42 renal transplant patients were retrieved:59.5%males,90.5%were whites and 66.7%were older than 60 years old.The mean duration since renal transplantation of the patients was 8.8±7.4 years.The most common risk factors for the development of end-stage renal disease in the subjects were hypertension(19.0%),polycystic kidney disease(19.0%),followed by diabetic nephropathy(16.7%)and chronic glomerulonephritis(16.7%).The main indications for NOACs use in the cohort were atrial fibrillation in 25 patients(59.5%)and venous thromboembolism in 10 patients(23.8%).Overall,29 patients(69%)were treated with apixaban,10 patients(23.8%)with rivaroxaban and 3 patients(7.14%)with dabigatran.No(0%)thromboembolic events were observed during the one-year period,but 3(7.1%)bleeding events occurred in the cohort consisting of 1 patient treated with rivaroxaban 15 mg daily and 2 patients who received apixaban 2.5 mg twice daily.There were no significant changes in serum tacrolimus level three days after the initiation of NOACs among patients treated with tacrolimus(pre-and post-NOACs tacrolimus levels were 7.2516 and 7.8867 ng/m L,P=0.55,respectively).Also,after one-year of treatment with NOACs there were no significant changes in the pre-and post-NOACs serum creatinine level(P=0.772)and estimated glomerular filtration rates(P=0.232).CONCLUSION No thromboembolic events or significant changes in renal profile were observed in our cohort of kidney transplant recipients who were treated with NOACs for at least a year.However,a few bleeding events were observed.This calls for further well-planned randomized controlled trials to assess the efficacy and safety of NOACs among renal transplant recipients.Muhammad A Bukhari Abdulrahman Al-Theaby Mohammed Tawhari Ali Al-Shaggag Ryan Pyrke Azim Gangji Darin Treleaven Christine Ribic 2019World Journal of Transplantation2019,9,6:1
17AAV4-mediated expression of IGF-1 and VEGF within cellular components of the ventricular system improves survival outcome in familial ALS mice显示文摘Dodge JC Treleaven CM Fidler JA 2010Mol Ther2010,18,12:1
18Systemic candidiasis with candida vasculitis due to Candida kruzei in a patient with acute myeloid leukaemia显示文摘Gregory R K Powles R L Treleaven J G 1999Bone Marrow Transplant1999,23,1:1
19Genetic algorithm programming environments显示文摘Filho J L R Treleaven P C Alippi C 1994IEEE Comput1994,,27:1
20The role of autologous transplantation in patients with multiple myeloma aged 65 years and over显示文摘Sirohi B Powles R Treleaven J 2000Bone Marrow Transplant2000,25,5:1
返回顶部 每页显示:
共4页 首页 上一页 第1页 下一页 末页 /4 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费